SEBI bars Ranbaxy's investment co.

The Securities and Exchange Board of India on Thursday barred Vidyut Investment Limited (VIL), the financial services arm of Ranbaxy Laboratories, from dealing in securities for two years citing its involvement with the Ketan Parekh (KP) Group.